Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Conclusions: Our analysis provided evidence that the use of immune checkpoint inhibitors is associated with an increased risk of all-grade pneumonitis compared with chemotherapy or placebo controls.
Source: Therapeutic Advances in Respiratory Disease - Category: Respiratory Medicine Authors: Tags: Original Research Source Type: research